In this roundtable, moderated by DDW and sponsored by Azenta Life Sciences, you will learn about the biggest challenges related to the delivery of RNA therapeutics.
Roundtable panellists include Dr Philip Cruz, UK Medical Director, Moderna, Dr Neill Liptrott, Reader in Pharmacology and Immuno-compatability, University of Liverpool, and Reece Armstrong, Editor, DDW.
Panellists will address the following questions:
- How has the Covid-19 pandemic influenced the advancement of RNA research?
- What does the investment landscape look like for RNA therapeutics after Covid?
- What are some of the biggest challenges related to the delivery of RNA therapeutics?
- What does the RNA pipeline look like across disease areas?
The roundtable discussion will be followed by a Q&A, and will include a presentation from Andrea O’Hara, PhD, Strategic Technical Specialist, Azenta Life Sciences.